Consensus Transgene OTC Markets

Stocks

TRGNF

FR0005175080

Biotechnology & Medical Research

Market Closed - OTC Markets 13:41:16 2026-08-14 EDT			5-day change	1st Jan Change
0.8000 ^USD	-5.88%		-.--%	-20.00%

09-25	Transgene provides update on its operations
09-08	Transgene Expands ProBioGen Partnership With Additional License	MT

Evolution of the Average Target: Transgene

Data source: Transgene(TNG)

Evolution of the Average Target - Transgene

Evolution of the Target Price: Transgene

Data source: Transgene(TNG)

Evolution of the Target Price - Transgene

Changes in Analyst Recommendations: Transgene

Data source: Transgene(TNG)

ad395f07b8f908d4cde87c9714d.WlBp0QdGSG2IOAHHssD3jWUDCtNLOwxOjo23fKNL0jI.HgEQ5D40DATaV3ihh_aGzyZrJ7gpTUsv-sziFI46nFUZGTmISRwEI_hONQ~a9d794b1f5b05f0dabe8ca8c6dadc4ed

Analysts' recommendations: Transgene

06-25	Oddo BHF Stays Positive on Transgene
04-07	Transgene stands out following licensing agreement with NEC Bio
11-27	Oddo BHF Lowers Target Price on Transgene but Remains Upbeat
25-10-13	Transgene and BioInvent International AB Jointly Present a Poster on Transational Data and Updated Clinical Results from the Phase I Study of BT-001	CI
25-09-18	Transgene: analysts reiterate their recommendations after results
25-09-17	The day the Fed resumed its rate cuts
24-11-06	Transgene: Invest Securities remains Buy
24-10-15	Transgene: Invest Securities confirms its Buy recommendation
24-09-26	Transgene: Invest Securities confirms its opinion
23-06-06	Transgene: Invest Securities confirms its Buy rating
23-06-05	Transgene: Invest Securities reiterates its recommendation
23-03-22	Transgene: Invest Securities reduces its target
23-01-10	Transgene: Invest Securities confirms its Buy rating

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	WUXI APPTEC CO., LTD.					+13.99%
	ARGENX SE					+24.63%
	LONZA GROUP AG					+19.23%
	REVOLUTION MEDICINES, INC.					+28.86%
	IQVIA HOLDINGS INC.					+13.19%
	BEONE MEDICINES AG					+19.55%
	CELLTRION, INC.					+45.91%
	BIONTECH SE					+22.24%
	GENMAB A/S					+2.02%
	Average					+21.07%
	Weighted average by Cap.					+20.74%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.6850EUR

Average target price

1.100EUR

Spread / Average Target

+60.58%

High Price Target

1.100EUR

Spread / Highest target

+60.58%

Low Price Target

1.100EUR

Spread / Lowest Target

+60.58%

Analyst Consensus Detail

Analyst consensus - Transgene

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Transgene

The best tools reserved for subscribers to boost the performance of your investments!